CompletedNot Applicable

The Effect of Auricular Press Needle on Visual Analogue Scale (VAS) and Short Form (SF-12) Scores in Chronic Pain With Depression Symptoms

Indonesia60 participantsStarted 2024-07-11

Plain-language summary

Chronic pain is a medical and social problem that can significantly impact the quality of life. Chronic pain is an important risk factor in the development of depression. It is shown by the significantly higher prevalence of depression in individuals who experience chronic pain (20-80%). Apart from that, chronic pain and depression also have a close relationship in the development of disease and mutually influence the severity of each condition. To reduce the cost of pain management from a pharmacological perspective and its use in the long term, it is necessary to consider other non-pharmacological treatment methods that have good therapeutic effects with minimal side effects. Acupuncture has become a non-pharmacological therapy option that has proven its effectiveness and safety in treating chronic pain in depressed patients. Previous literature has reported the effectiveness of acupuncture therapy, especially auricular acupuncture in treating pain. Auricular acupuncture therapy using press needles is quite easy to apply, fast, and can provide continuous stimulation with minimal side effects. This study aimed to assess the effectiveness of the auricular needle press in chronic pain with depressive symptoms. This study was a double-blinded randomized clinical trial and was carried out on outpatients at Dr. Cipto Mangunkusumo National General Hospital Jakarta and Soerojo Hospital Magelang. This is also a collaborative study between the medical acupuncture department and the psychiatry department. This study includes 60 participants who will be randomly allocated into 2 groups, the press needle and sham press needle groups. The press needles will be placed at 6 auricular points bilaterally, which are MA-TF1 Shenmen, MA-IC7 Heart, and MA-IT1 Cingulate gyrus. The outcomes that will be assessed in this study are pain intensity using the visual analog scale (VAS) and quality of life using the short form-12 (SF-12) as well as time-to-event achievement in the form of a decrease in the VAS score \>= 14 mm.

Who can participate

Age range18 Years – 59 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Men or women aged 18-59 years. * Subjects who experience chronic pain with symptoms of depression. * Subjects with VAS \>= 30 mm and \< 70 mm from 100 mm during activity (daily activities or light exercise). * Duration of pain \> 3 months. * Patient Health Questionnaire-9 Items (PHQ-9) score 5-19 on a scale of 0-27. * Willing to take part in this study until completion and sign the informed consent. Exclusion Criteria: * Pain caused by malignancy. * Patients diagnosed with major depression, depressive symptoms accompanied by psychotic symptoms, and depressive symptoms with antidepressant therapy. * Patients with medical emergencies or pregnancy. * Infection, scar tissue, or malignancy at the acupuncture area. * Anatomical abnormalities in the ear shape. * Having hypersensitivity reaction to previous acupuncture therapy (metal allergy, atopy, keloid, or other skin hypersensitivity). * Patients with cognitive impairment or impaired consciousness.

What they're measuring

Visual Analog Scale

Timeframe: [Time Frame: first 24 hours, the third day, seventh day, and fourteenth-day post intervention]

Short Form-12

Timeframe: [Time Frame: on the seventh day and fourteenth-day post-intervention]

Trial details

NCT IDNCT06401031

SponsorIndonesia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-30